RHEUMATOID ARTHRITIS-MANAGEMENT (DMARDs & NON DMARDs)

From NeuroRehab.wiki

Revision as of 11:30, 1 January 2023 by Dr Appukutty Manickam (talk | contribs) (Imported from text file)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

SUMMARY
DMARD (first line)


1. Non-biologic agents: hydroxychloroquine, sulfasalazine, methotrexate, cyclosporin, azathioprine.
2. Biologic agents that inhibit TNF (anti-TNF): infliximab, adalimumab, certolizumab, and golimumab are monoclonal antibodies that bind and inactivate TNF.

3. Biologic agents that inhibit other factors: rituximab (anti-CD20 antibodies), anakinra (IL-1 antagonist), tocilizumab (IL-6 antagonist).

NON-DMARD (should only be used as adjuncts)
4. Aspirin (ASA), NSAIDs, COX-2 inhibitors. SE: GI ulceration and bleeding, renal insufficiency, hepatotoxicity, HTN.
5. Corticosteroids. SE: hyperglycemia, immune suppression, osteoporosis, peptic ulcer disease, steroid psychosis. Corticosteroids help to reduce acute inflammation but are less efficacious in the long term.


Reference(s)

Wilkinson, I. (2017). Oxford handbook of clinical medicine. Oxford: Oxford University Press.
Hannaman, R. A., Bullock, L., Hatchell, C. A., & Yoffe, M. (2016). Internal medicine review core curriculum, 2017-2018. CO Springs, CO: MedStudy.
Therapeutic Guidelines. Melbourne: Therapeutic Guidelines Limited. https://www.tg.org.au [Accessed 2021].